APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Influenza Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Influenza Drugs Industry Growth and Trends Forecast to 2032

Report ID 174002660120 December 2025113 pages

Choose your research edition.

Industry ResearchInfluenza Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Influenza Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Influenza Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Influenza Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Influenza Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Influenza Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Influenza Drugs include Novartis, Roche, Eli Lilly, Pfizer, GlaxoSmithKline, Bayer, AstraZeneca, Serum Institute of India and Seqirus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Influenza Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Influenza Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Influenza Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Influenza Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Influenza Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Influenza Drugs Market by Company

Novartis

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Serum Institute of India

Seqirus

Sanofi Pasteur

Protein Sciences Corporation

Emergent Biosolutions

Celgene

Bristol-Myers Squibb]

BioCryst Pharmaceuticals

Alvogen

Influenza Drugs Segment by Type

Oseltamivir Phosphate

Peramivir

Zanamivir

Other Influenza Drugs

Influenza Drugs Segment by Application

Adults

Chidren

Influenza Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Influenza Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Influenza Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oseltamivir Phosphate Table 2. Major Company of Peramivir Table 3. Major Company of Zanamivir Table 4. Major Company of Other Influenza Drugs Table 5. Global Influenza Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 7. Global Influenza Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Influenza Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Influenza Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Influenza Drugs Price by Type (2021-2026) & (US$/Ton) Table 11. Global Influenza Drugs Sales by Type (2027-2032) & (K Tons) Table 12. Global Influenza Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Influenza Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Influenza Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Influenza Drugs Price by Type (2027-2032) & (US$/Ton) Table 16. North America Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 17. North America Influenza Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 19. Europe Influenza Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 21. Asia-Pacific Influenza Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 23. Latin America Influenza Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 25. Middle East and Africa Influenza Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Influenza Drugs Industry Trends Table 27. Influenza Drugs Industry Drivers Table 28. Influenza Drugs Industry Opportunities and Challenges Table 29. Influenza Drugs Industry Restraints Table 30. Global Influenza Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Influenza Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Influenza Drugs Sales by Company (2021-2026) & (K Tons) Table 33. Global Influenza Drugs Sales Share by Company (2021-2026) Table 34. Global Influenza Drugs Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Influenza Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Influenza Drugs Major Company Production Sites and Headquarters Table 37. Global Influenza Drugs Company, Product Type & Application Table 38. Global Influenza Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Influenza Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Influenza Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Influenza Drugs Sales by Region (2021-2026) & (K Tons) Table 43. Global Influenza Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Influenza Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Influenza Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Influenza Drugs Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Influenza Drugs Sales by Region (2027-2032) & (K Tons) Table 48. Global Influenza Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Influenza Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Influenza Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Influenza Drugs Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Influenza Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 54. Global Influenza Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Influenza Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Influenza Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Influenza Drugs Price by Application (2021-2026) & (US$/Ton) Table 58. Global Influenza Drugs Sales by Application (2027-2032) & (K Tons) Table 59. Global Influenza Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Influenza Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Influenza Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Influenza Drugs Price by Application (2027-2032) & (US$/Ton) Table 63. North America Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 64. North America Influenza Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 66. Europe Influenza Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 68. Asia-Pacific Influenza Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 70. Latin America Influenza Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 72. Middle East and Africa Influenza Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Novartis Influenza Drugs Product Portfolio Table 77. Novartis Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Roche Influenza Drugs Product Portfolio Table 82. Roche Recent Development Table 83. Eli Lilly Company Information Table 84. Eli Lilly Business Overview Table 85. Eli Lilly Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Eli Lilly Influenza Drugs Product Portfolio Table 87. Eli Lilly Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Pfizer Influenza Drugs Product Portfolio Table 92. Pfizer Recent Development Table 93. GlaxoSmithKline Company Information Table 94. GlaxoSmithKline Business Overview Table 95. GlaxoSmithKline Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. GlaxoSmithKline Influenza Drugs Product Portfolio Table 97. GlaxoSmithKline Recent Development Table 98. Bayer Company Information Table 99. Bayer Business Overview Table 100. Bayer Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Bayer Influenza Drugs Product Portfolio Table 102. Bayer Recent Development Table 103. AstraZeneca Company Information Table 104. AstraZeneca Business Overview Table 105. AstraZeneca Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. AstraZeneca Influenza Drugs Product Portfolio Table 107. AstraZeneca Recent Development Table 108. Serum Institute of India Company Information Table 109. Serum Institute of India Business Overview Table 110. Serum Institute of India Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Serum Institute of India Influenza Drugs Product Portfolio Table 112. Serum Institute of India Recent Development Table 113. Seqirus Company Information Table 114. Seqirus Business Overview Table 115. Seqirus Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Seqirus Influenza Drugs Product Portfolio Table 117. Seqirus Recent Development Table 118. Sanofi Pasteur Company Information Table 119. Sanofi Pasteur Business Overview Table 120. Sanofi Pasteur Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Sanofi Pasteur Influenza Drugs Product Portfolio Table 122. Sanofi Pasteur Recent Development Table 123. Protein Sciences Corporation Company Information Table 124. Protein Sciences Corporation Business Overview Table 125. Protein Sciences Corporation Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Protein Sciences Corporation Influenza Drugs Product Portfolio Table 127. Protein Sciences Corporation Recent Development Table 128. Emergent Biosolutions Company Information Table 129. Emergent Biosolutions Business Overview Table 130. Emergent Biosolutions Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Emergent Biosolutions Influenza Drugs Product Portfolio Table 132. Emergent Biosolutions Recent Development Table 133. Celgene Company Information Table 134. Celgene Business Overview Table 135. Celgene Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Celgene Influenza Drugs Product Portfolio Table 137. Celgene Recent Development Table 138. Bristol-Myers Squibb] Company Information Table 139. Bristol-Myers Squibb] Business Overview Table 140. Bristol-Myers Squibb] Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Bristol-Myers Squibb] Influenza Drugs Product Portfolio Table 142. Bristol-Myers Squibb] Recent Development Table 143. BioCryst Pharmaceuticals Company Information Table 144. BioCryst Pharmaceuticals Business Overview Table 145. BioCryst Pharmaceuticals Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. BioCryst Pharmaceuticals Influenza Drugs Product Portfolio Table 147. BioCryst Pharmaceuticals Recent Development Table 148. Alvogen Company Information Table 149. Alvogen Business Overview Table 150. Alvogen Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 151. Alvogen Influenza Drugs Product Portfolio Table 152. Alvogen Recent Development Table 153. North America Influenza Drugs Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 154. North America Influenza Drugs Sales by Country (2021-2026) & (K Tons) Table 155. North America Influenza Drugs Sales Market Share by Country (2021-2026) Table 156. North America Influenza Drugs Sales Forecast by Country (2027-2032) & (K Tons) Table 157. North America Influenza Drugs Sales Market Share Forecast by Country (2027-2032) Table 158. North America Influenza Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Influenza Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Influenza Drugs Market Share by Country (2021-2026) Table 161. North America Influenza Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Influenza Drugs Market Share Forecast by Country (2027-2032) Table 163. Europe Influenza Drugs Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 164. Europe Influenza Drugs Sales by Country (2021-2026) & (K Tons) Table 165. Europe Influenza Drugs Sales Market Share by Country (2021-2026) Table 166. Europe Influenza Drugs Sales Forecast by Country (2027-2032) & (K Tons) Table 167. Europe Influenza Drugs Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Influenza Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Influenza Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Influenza Drugs Market Share by Country (2021-2026) Table 171. Europe Influenza Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Influenza Drugs Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Influenza Drugs Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Influenza Drugs Sales by Country (2021-2026) & (K Tons) Table 175. Asia-Pacific Influenza Drugs Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Influenza Drugs Sales Forecast by Country (2027-2032) & (K Tons) Table 177. Asia-Pacific Influenza Drugs Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Influenza Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Influenza Drugs Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Influenza Drugs Market Share by Country (2021-2026) Table 181. Asia-Pacific Influenza Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Influenza Drugs Market Share Forecast by Country (2027-2032) Table 183. Latin America Influenza Drugs Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 184. Latin America Influenza Drugs Sales by Country (2021-2026) & (K Tons) Table 185. Latin America Influenza Drugs Sales Market Share by Country (2021-2026) Table 186. Latin America Influenza Drugs Sales Forecast by Country (2027-2032) & (K Tons) Table 187. Latin America Influenza Drugs Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Influenza Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Influenza Drugs Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Influenza Drugs Market Share by Country (2021-2026) Table 191. Latin America Influenza Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Influenza Drugs Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Influenza Drugs Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Influenza Drugs Sales by Country (2021-2026) & (K Tons) Table 195. Middle East and Africa Influenza Drugs Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Influenza Drugs Sales Forecast by Country (2027-2032) & (K Tons) Table 197. Middle East and Africa Influenza Drugs Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Influenza Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Influenza Drugs Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Influenza Drugs Market Share by Country (2021-2026) Table 201. Middle East and Africa Influenza Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Influenza Drugs Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Influenza Drugs Distributors List Table 206. Influenza Drugs Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Influenza Drugs Image Figure 2. Global Influenza Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Influenza Drugs Sales (2021-2032) & (K Tons) Figure 5. Oseltamivir Phosphate Image Figure 6. Global Oseltamivir Phosphate Sales YoY Growth (2021-2032) & (K Tons) Figure 7. Peramivir Image Figure 8. Global Peramivir Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Zanamivir Image Figure 10. Global Zanamivir Sales YoY Growth (2021-2032) & (K Tons) Figure 11. Other Influenza Drugs Image Figure 12. Global Other Influenza Drugs Sales YoY Growth (2021-2032) & (K Tons) Figure 13. Global Influenza Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Influenza Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Influenza Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Influenza Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Influenza Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Influenza Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Influenza Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Influenza Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Influenza Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Influenza Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Influenza Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Influenza Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Influenza Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adults Image Figure 28. Global Adults Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Chidren Image Figure 30. Global Chidren Sales YoY Growth (2021-2032) & (K Tons) Figure 31. Global Influenza Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Influenza Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Influenza Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Influenza Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Influenza Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Influenza Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Influenza Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Influenza Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Influenza Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Influenza Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Influenza Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Influenza Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Influenza Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 44. North America Influenza Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Influenza Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Influenza Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Influenza Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 48. Europe Influenza Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Influenza Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Influenza Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Influenza Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 52. Asia-Pacific Influenza Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Influenza Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Influenza Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Influenza Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 56. Latin America Influenza Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Influenza Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Influenza Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Influenza Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 60. Middle East and Africa Influenza Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Influenza Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Influenza Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Influenza Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Influenza Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oseltamivir Phosphate
  • Peramivir
  • Zanamivir
  • Other Influenza Drugs
Applications
  • Adults
  • Chidren
Companies covered
  • Novartis
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Serum Institute of India
  • Seqirus
  • Sanofi Pasteur
  • Protein Sciences Corporation
  • Emergent Biosolutions
  • Celgene
  • Bristol-Myers Squibb]
  • BioCryst Pharmaceuticals
  • Alvogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Influenza Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Influenza Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Influenza Drugs Market by Type
  6. 1.3.1 Oseltamivir Phosphate
  7. 1.3.2 Peramivir
  8. 1.3.3 Zanamivir
  9. 1.3.4 Other Influenza Drugs
  10. 1.4 Global Influenza Drugs Market Size by Type
  11. 1.4.1 Global Influenza Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Influenza Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Influenza Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Influenza Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Influenza Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Influenza Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Influenza Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Influenza Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Influenza Drugs Industry Trends
  2. 2.2 Influenza Drugs Industry Drivers
  3. 2.3 Influenza Drugs Industry Opportunities and Challenges
  4. 2.4 Influenza Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Influenza Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Influenza Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Influenza Drugs Price (2021-2026)
  4. 3.4 Global Influenza Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Influenza Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Influenza Drugs Company, Product Type & Application
  7. 3.7 Global Influenza Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Influenza Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Influenza Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Influenza Drugs Tier 1, Tier 2, and Tier 3
4 Influenza Drugs Regional Status and Outlook
  1. 4.1 Global Influenza Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Influenza Drugs Historic Market Size by Region
  3. 4.2.1 Global Influenza Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Influenza Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Influenza Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Influenza Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Influenza Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Influenza Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Influenza Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Influenza Drugs by Application
  1. 5.1 Influenza Drugs Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Chidren
  4. 5.2 Global Influenza Drugs Market Size by Application
  5. 5.2.1 Global Influenza Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Influenza Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Influenza Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Influenza Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Influenza Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Influenza Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Influenza Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Influenza Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Influenza Drugs Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Influenza Drugs Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Influenza Drugs Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Influenza Drugs Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Influenza Drugs Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Influenza Drugs Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Influenza Drugs Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Serum Institute of India
  44. 6.8.1 Serum Institute of India Company Information
  45. 6.8.2 Serum Institute of India Business Overview
  46. 6.8.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Serum Institute of India Influenza Drugs Product Portfolio
  48. 6.8.5 Serum Institute of India Recent Developments
  49. 6.9 Seqirus
  50. 6.9.1 Seqirus Company Information
  51. 6.9.2 Seqirus Business Overview
  52. 6.9.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Seqirus Influenza Drugs Product Portfolio
  54. 6.9.5 Seqirus Recent Developments
  55. 6.10 Sanofi Pasteur
  56. 6.10.1 Sanofi Pasteur Company Information
  57. 6.10.2 Sanofi Pasteur Business Overview
  58. 6.10.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Pasteur Influenza Drugs Product Portfolio
  60. 6.10.5 Sanofi Pasteur Recent Developments
  61. 6.11 Protein Sciences Corporation
  62. 6.11.1 Protein Sciences Corporation Company Information
  63. 6.11.2 Protein Sciences Corporation Business Overview
  64. 6.11.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Protein Sciences Corporation Influenza Drugs Product Portfolio
  66. 6.11.5 Protein Sciences Corporation Recent Developments
  67. 6.12 Emergent Biosolutions
  68. 6.12.1 Emergent Biosolutions Company Information
  69. 6.12.2 Emergent Biosolutions Business Overview
  70. 6.12.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Emergent Biosolutions Influenza Drugs Product Portfolio
  72. 6.12.5 Emergent Biosolutions Recent Developments
  73. 6.13 Celgene
  74. 6.13.1 Celgene Company Information
  75. 6.13.2 Celgene Business Overview
  76. 6.13.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Celgene Influenza Drugs Product Portfolio
  78. 6.13.5 Celgene Recent Developments
  79. 6.14 Bristol-Myers Squibb]
  80. 6.14.1 Bristol-Myers Squibb] Company Information
  81. 6.14.2 Bristol-Myers Squibb] Business Overview
  82. 6.14.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bristol-Myers Squibb] Influenza Drugs Product Portfolio
  84. 6.14.5 Bristol-Myers Squibb] Recent Developments
  85. 6.15 BioCryst Pharmaceuticals
  86. 6.15.1 BioCryst Pharmaceuticals Company Information
  87. 6.15.2 BioCryst Pharmaceuticals Business Overview
  88. 6.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 BioCryst Pharmaceuticals Influenza Drugs Product Portfolio
  90. 6.15.5 BioCryst Pharmaceuticals Recent Developments
  91. 6.16 Alvogen
  92. 6.16.1 Alvogen Company Information
  93. 6.16.2 Alvogen Business Overview
  94. 6.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Alvogen Influenza Drugs Product Portfolio
  96. 6.16.5 Alvogen Recent Developments
7 North America by Country
  1. 7.1 North America Influenza Drugs Sales by Country
  2. 7.1.1 North America Influenza Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Influenza Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Influenza Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Influenza Drugs Market Size by Country
  6. 7.2.1 North America Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Influenza Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Influenza Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Influenza Drugs Sales by Country
  2. 8.1.1 Europe Influenza Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Influenza Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Influenza Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Influenza Drugs Market Size by Country
  6. 8.2.1 Europe Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Influenza Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Influenza Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Influenza Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Influenza Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Influenza Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Influenza Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Influenza Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Influenza Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Influenza Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Influenza Drugs Sales by Country
  2. 10.1.1 South America Influenza Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Influenza Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Influenza Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Influenza Drugs Market Size by Country
  6. 10.2.1 South America Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Influenza Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Influenza Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Influenza Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Influenza Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Influenza Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Influenza Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Influenza Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Influenza Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Influenza Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Influenza Drugs Value Chain Analysis
  2. 12.1.1 Influenza Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Influenza Drugs Production Mode & Process
  7. 12.2 Influenza Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Influenza Drugs Distributors
  10. 12.2.3 Influenza Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst